Zhipeng Li

Biochemistry, Genetics and Molecular BiologyMedicine

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 6 papers. Top paper: “Identification of structurally diverse FSP1 inhibitors that sensitize cancer cells to ferroptosis”.

Identification of structurally diverse FSP1 inhibitors that sensitize cancer cells to ferroptosis

Cell chemical biology(2023)10.1016/j.chembiol.2023.04.007

N/A

0.700DataRank · unranked

105 citations

Cody E. Doubravsky, Eddie Wehri, Zhipeng Li, Melissa A. Roberts, Kirandeep K. Deol +8 more

Ribosome stalling during selenoprotein translation exposes a ferroptosis vulnerability in cancer

bioRxiv (Cold Spring Harbor Laboratory)(2022)10.1101/2022.04.11.487892

N/A

0.165DataRank · unranked

2 citations

Lucas Ferguson, Kirandeep K. Deol, Melissa A. Roberts, Leslie Magtanong, Michael C. Bassik +4 more

Ribosome stalling during selenoprotein translation exposes a ferroptosis vulnerability

Nature Chemical Biology(2022)10.1038/s41589-022-01033-3

N/A

0DataRank · unranked

134 citations

Lucas Ferguson, Kirandeep K. Deol, Melissa A. Roberts, Leslie Magtanong, Joseph M. Hendricks +10 more

Identification of structurally diverse FSP1 inhibitors that sensitize cancer cells to ferroptosis

bioRxiv (Cold Spring Harbor Laboratory)(2022)10.1101/2022.12.14.520445

N/A

0DataRank · unranked

11 citations

Cody E. Doubravsky, Eddie Wehri, Zhipeng Li, Melissa A. Roberts, Kirandeep K. Deol +7 more

Lipid Quality Control and Ferroptosis: From Concept to Mechanism

Annual Review of Biochemistry(2023)10.1146/annurev-biochem-052521-033527

N/A

0DataRank · unranked

58 citations

Mike Lange, Scott J. Dixon, James A. Olzmann, Zhipeng Li

Protocol for performing pooled CRISPR-Cas9 loss-of-function screens

STAR Protocols(2023)10.1016/j.xpro.2023.102201

N/A

0DataRank · unranked

19 citations

Melissa A. Roberts, David W. Morgens, James A. Olzmann, Zhipeng Li, Alyssa J. Mathiowetz